Prevention of vertical transmission of HIV: Analysis of cost effectiveness of options available in South Africa

British Medical Journal

Volumn 318, Issue 7199, 1999, Pages 1650-1656

  Söderlund, Neil ^a   Zwi, Karen ^b   Kinghorn, Anthony ^c   Gray, Glenda ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c Cancer Association of South Africa   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ARTICLE; ARTIFICIAL MILK; BREAST FEEDING; COST EFFECTIVENESS ANALYSIS; FOLLOW UP; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT MORTALITY; LIFE EXPECTANCY; MATHEMATICAL MODEL; PRIORITY JOURNAL; PROBABILITY; SOUTH AFRICA; VERTICAL TRANSMISSION;

EID: 0033584017     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.318.7199.1650     Document Type: Article

References (35)

1. 1 Stover J, Way P. Projecting the impact of AIDS on mortality. AIDS 1998;12:S29-39.
2. 2 Dabis F, Msellati P, Meda N, Welffens-Ekra C, You B, Olivier M, et al. 6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Cote d'Ivoire and Burkino Faso: a double-blind placebo-controlled multicentre trial. Lancet 1999;353:786-92.
3. 3 Wiktor SZ, Ekpini E, Karon JM, Nkengasong J, Maurice C, Severin ST, et al. Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Cote d'Ivoire: a randomised trial. Lancet 1999;353:781-5.
4. 4 Shaffer N, Chuachoowong R, Mock PA, Bhadrakom C, Siriwasin W, Young NL, et al. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Lancet 1999;353:773-80.
5. 5 Ratcliffe J, Ades AE, Gibb D, Sculpher MJ, Briggs AH. Prevention of mother-to-child transmission of HIV-1 infection: alternative strategies and their cost-effectiveness. AIDS 1998;12:1381-8.
6. 6 Nicoll A, Newell ML, Von Praag E, Van de Perre P, Peckham C. Infant feeding policy and practice in the presence of HIV-1 infection. AIDS 1995;9:107-19.
7. 7 Mofenson LM. Interaction between timing of potential human immunodeficiency virus infection and the design of preventive and therapeutic interventions. Acta Paediatr Suppl 1997;421:1-9.
8. 8 Connor EM, Sperling RS, Gelber R, Kiselev O, Scott G, O'Sullivan MJ, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treament. Pediatric AIDS clinical trials group protocol 076 study group. N Engl J Med 1994;331:1473-80.
9. 9 Mayaux MJ, Teglas JP, Mandelbrot L, Berrebi A, Gallais H, Matheron S, et al. Acceptability and impact of zidovudine prevention on mother-to-child HIV-1 transmission in France. J Pediatr 1997;131:857-62.
10. 10 Dunn DT, Newell ML, Mayaux, Kind C, Hutto C, Goedert JJ, et al. Mode of delivery and vertical transmission of HIV-1: a review of prospective studies. Perinatal AIDS collaborative transmission studies. J AIDS Hum Retrovirol 1994;7:1064-6.
11. 11 Sculpher MJ, Gibb D, Ades AE, Ratcliffe J, Duong T. Modelling the costs of paediatric HIV infection and AIDS: comparison of infected children born to screened and unscreened mothers. AIDS 1998;12:1371-80.
12. 12 Biggar RJ, Miotti PG, Taha, Mtimavalye L, Broadhead R, Justesen A, et al. Perinatal intervention trial in Africa: effect of birth canal cleansing intervention to prevent HIV transmission. Lancet 1996;347:1647-50.
13. 13 Semba RD, Miotti PG, Chipangwi J, Saah AJ, Canner JK, Dallabetta GA, et al. Maternal Vitamin A deficiency and mother-to-child transmission of HIV-1. Lancet 1994;343:1593-7.
14. 14 UNAIDS and World Health Organisation. Guidance modules im anti-retroviral treatments -module 6. The use of antiretroviral drugs to reduce mother to child transmission of HIV. Geneva: UNAIDS/WHO, 1998.
15. 15 Marseilles E, Kahn JG, Saba J. Cost-effectiveness of anti-retroviral drug therapy to reduce mother-to-child HIV transmission in sub-Saharan Africa. AIDS 1998;12:939-48.
16. 16 Mansergh G, Haddix AC, Steketee RW, Nieburg PI, Hu DJ, Simonds RJ. et al. Cost-effectiveness of short-course zidovudine to prevent perinatal HIV type 1 infection in a sub-Saharan African developing country setting. JAMA 1996;276:139-45.
17. 17 Wilkinson D, Floyd K, Gilks CF. Antiretroviral drugs as a public health intervention for pregnant women in rural South Africa: an issue of cost-effectiveness and capacity. AIDS 1998;12:1675-82.
18. 18 Centres for Disease Control and Prevention. Administration of zidovudine during late pregnancy and delivery to prevent perinatal HIV transmission Thailand, 1996-1998. MMWR 1998;47:151-4.
19. 19 Department of Health and Population Development, South Africa. Seventh national HIV survey of women attending antenatal clinics of the public health services in the Republic of South Africa, October/ November 1996. Epidemiological Comments 1996;23:4-16.
20. 20 Harrison D, Nielson M, ed. South African health review - 1995. Durban: Health Systems Trust and the Henry J Kaiser Foundation, 1995.
21. 21 World Bank. World development report 1993 - investing in health. New York: Oxford University Press, 1993.
22. 22 Wagstaff L, de Wet T, Anderson A. Infant feeding: birth to ten. Urbanisa tum and Health Newsletter 1993;18:9-16.
23. 23 Ross SM, van Middelkoop A, Khoza NC. Breast feeding practices in a black community. S Afr Med J 1983;63:23-5.
24. 24 Central Statistical Service. Statistics in brief - 1997. Pretoria: Central Statistical Service, 1997.
25. 25 Cunningham AS, Jelliffe DB, Patrice Jelliffe EF. Breast-feeding and health in the 1980s; a global epidemiologic review. J Pediatr 1991;118:659-66.
26. 26 Kinghorn AW. Projections of the costs of anti-retroviral interventions to reduce mother-to-child transmission of HIV in the South African public sector. Johannesburg: HIV Management Services Technical Report, 1998.
27. 27 Zwi KJ, Pettilor JM, Söderlund RN. Paediatric hospital admissions at a South African urban regional hospital: the impact of HIV 1992-1997. Ann Trop Paed (in press).
28. 28 Söderlund N. Likely costs of hospital care benefits to be covered by a Social Health Insurance fund a report to the National Department of Health. Johannesburg: Centre for Health Policy, 1997.
29. 29 Söderlund N, Peprah E. An essential hospital package for South Africa - selection criteria, costs and affordability. Johannesburg: Centre for Health Policy, 1998. (Monograph No 52.)
30. 30 Brown M, van den Heever A. Report by the consultants on the existing expenditure trends and functional costs to support the function analysis and rationalisation programme in terms of the National Health Plan and the Reconstruction and Development Programme. Johannesburg. PWV Province Health Strategic Management Team, 1994.
31. 31 Regional Health Management Information System (ReHMIS). Pretoria: National Department of Health of South Africa, 1995.
32. 32 Briggs A, Sculpher M. An introduction to Markov modelling for economic evaluation. Pharmacoeconomics 1998;13:397-409.
33. 33 Tess BH, Rodrigues LC, Newell ML, Dunn DT, Lago TD. Infant feeding and risk of mother-to-child transmission of HIV in Sao Paulo State, Brazil. Sao Paulo collaborative study for vertical transmission of HIV-1. J AIDS Hum Retrovirol 1998;19:189-94.
34. 34 Bertolli J, St Louis ME, Simonds RJ, Nieburg P. Kamenga M, Brown C, et al. Estimating the timing of mother-to-child transmission of human immunodeficiency virus in a breastfeeding population in Kinshasa, Zaire. J Infect Dis 1996;174:722-6.
35. 35 UNAIDS and World Health Organisation. Guidance modules on antiretroviral treatments module 2. Introducing antiretroviral treatment into health systems: economic considerations. Geneva: UNAIDS/WHO, 1998. (Accepted 30 March 1999)